NCT01320553

Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 122 (actual)
• Sponsor: Sun Pharma Advanced Research Company Limited · Industry
• Sex: All
• Age: 10 Years
• Healthy volunteers: Not accepted

Summary

The present study will test if administration of different concentrations of 1334H eyedrops will be effective in treatment of allergic conjunctivitis in people with 10 yrs of age or older.

Conditions

• Allergic Conjunctivitis

Interventions

Type	Name	Description
DRUG	SPARC1102 I	SPARC1102 I will be administered in both eyes
DRUG	SPARC1102 II	SPARC1102 II will be administered in both eyes
DRUG	SPARC1102 III	SPARC1102 III will be administered in both eyes
DRUG	Vehicle	Vehicle will be administered in both eyes

Timeline

• Start date: 2011-06-01
• Primary completion: 2011-08-01
• Completion: 2011-09-01
• First posted: 2011-03-22
• Last updated: 2016-06-24
• Results posted: 2016-05-20

Locations

1 site across 1 country: United States